{"id":6516,"date":"2017-06-13T15:28:34","date_gmt":"2017-06-13T19:28:34","guid":{"rendered":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf"},"modified":"2017-06-13T15:28:34","modified_gmt":"2017-06-13T19:28:34","slug":"2374_ats_2017_report_en","status":"inherit","type":"attachment","link":"https:\/\/themedicalxchange.com\/en\/2017\/06\/13\/major-study-documents-additional-benefits-for-anti-il-5-therapies-in-severe-asthma\/2374_ats_2017_report_en\/","title":{"rendered":"2374_ATS_2017_report_EN"},"author":9,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-6516","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2374_ATS_2017_report_EN - The Medical Xchange<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2374_ATS_2017_report_EN - The Medical Xchange\" \/>\n<meta property=\"og:description\" content=\"2374_ATS_2017_report_EN\" \/>\n<meta property=\"og:url\" content=\"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf\" \/>\n<meta property=\"og:site_name\" content=\"The Medical Xchange\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/2374_ATS_2017_report_EN.pdf\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/2374_ATS_2017_report_EN.pdf\",\"name\":\"2374_ATS_2017_report_EN - The Medical Xchange\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\"},\"datePublished\":\"2017-06-13T19:28:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/2374_ATS_2017_report_EN.pdf#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/2374_ATS_2017_report_EN.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/2374_ATS_2017_report_EN.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Major Study Documents Additional Benefits for Anti-IL-5 Therapies in Severe Asthma\",\"item\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2017\\\/06\\\/13\\\/major-study-documents-additional-benefits-for-anti-il-5-therapies-in-severe-asthma\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"2374_ATS_2017_report_EN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\",\"name\":\"The Medical Xchange\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2374_ATS_2017_report_EN - The Medical Xchange","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf","og_locale":"en_US","og_type":"article","og_title":"2374_ATS_2017_report_EN - The Medical Xchange","og_description":"2374_ATS_2017_report_EN","og_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf","og_site_name":"The Medical Xchange","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf","url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf","name":"2374_ATS_2017_report_EN - The Medical Xchange","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/en\/#website"},"datePublished":"2017-06-13T19:28:34+00:00","breadcrumb":{"@id":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/themedicalxchange.com\/en\/"},{"@type":"ListItem","position":2,"name":"Major Study Documents Additional Benefits for Anti-IL-5 Therapies in Severe Asthma","item":"https:\/\/themedicalxchange.com\/en\/2017\/06\/13\/major-study-documents-additional-benefits-for-anti-il-5-therapies-in-severe-asthma\/"},{"@type":"ListItem","position":3,"name":"2374_ATS_2017_report_EN"}]},{"@type":"WebSite","@id":"https:\/\/themedicalxchange.com\/en\/#website","url":"https:\/\/themedicalxchange.com\/en\/","name":"The Medical Xchange","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/themedicalxchange.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf'>2374_ATS_2017_report_EN<\/a><\/p>\n"},"caption":{"rendered":"<p>2374_ATS_2017_report_EN<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":6508,"source_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2017\/06\/2374_ATS_2017_report_EN.pdf","_links":{"self":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/media\/6516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/users\/9"}],"wp:attached-to":[{"embeddable":true,"post_type":"post","id":6508,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/posts\/6508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}